Introduction
============

Genome sequencing of microorganisms has become a routinely used procedure and resulted in more than 300 completely sequenced bacterial genomes up to date (<http://www.tigr.org>). It is one of the major challenges of the post‐genomic era to extract useable information from this vast amount of sequence data by determining the function of proteins that have no ortho‐ or paralogues with known activities. Indeed, approximately one‐fourth of the open reading frames (ORFs) of the best‐studied bacterium *Escherichia coli* encode proteins whose function is still unknown ([@b81]). In general, this is the case for about 30--40% of the ORFs found in bacterial genomes. A widely used approach for delineating gene--function relationships is to create a deletion mutant and to determine the resulting phenotype. Obviously, this method is restricted to non‐essential genes and, more importantly, also fails for the analysis of genes that are critical under specific growth conditions, e.g. for intracellular growth. On the other hand, both essential genes and genes that need to be expressed for pathogenicity are preferred targets for developing novel anti‐infectives because it is assumed that bacteria cannot easily develop target modification‐based resistance against antibiotics acting on such vital functions. It is anticipated that some genes with unknown functions encode factors that could eventually be attacked by new classes of antibiotics.

In fact, there is an increasing need to combat bacterial infections with newly developed drugs, because the commonly used ones are more and more rapidly incapacitated by resistance development in pathogenic bacteria. These circumstances have generated substantial efforts directed at the elaboration of new high‐throughput methods to determine gene function, e.g. by conditional gene silencing so that the impact of the encoded proteins can be studied under various conditions. In general, there is no shortage of bacterial gene regulation systems that have successfully been exploited for that purpose. However, the optimal inducible regulation system for targetvalidation and evaluation should be able to reveal much more information than just whether a gene product is essential or not. A regulatory system allowing graded expression will yield information about the threshold amount of an essential protein necessary for survival, thereby defining the minimal inhibitory activity of a potential drug acting on this protein. This information might be a pivotal advantage for selecting a target for drug development. A regulatory system allowing graded expression in *in vivo* models, e.g. mice infected with pathogenic bacteria, could mimic drug activity by adjusting target protein expression to various levels. Thereby the effect of a potential drug on disease symptoms can be revealed or possible side‐effects originating from the physiological response of the pathogen to a drug, or the survival properties of the pathogen under treatment conditions can be monitored.

Regulation of bacterial genes within the infected host or host cells can only be accomplished if the effector for the regulatory system is readily applicable in mammals, is not or only slowly metabolized by the host and is taken up by the mammalian cells to reach intracellular pathogens. Tetracycline‐dependent gene regulatory systems fulfil these requirements. Tetracycline can slowly diffuse across natural and artificial membranes and hence can passively penetrate most cells (reviewed in [@b8]). Furthermore, as tc is being widely used as a drug since the mid‐1950s, its pharmacokinetics and slow metabolization rate in mammals are well established ([@b20]). For an efficient gene regulation system, it would additionally be desirable if one could turn a gene on or off at will within a large regulatory window as some proteins may only be needed in minute amounts while others must be highly expressed to fully exert their biological function. All of these advantageous properties are combined in tc‐dependent gene regulation (*tet* regulation).

The widespread use of *tet* regulation in the eukaryotic kingdom, in particular for the control of mammalian genes by means of TetR fused to mammalian transcription factor domains like VP16 for transactivation ([@b32]) or KRAB for transsilencing ([@b23]), is an impressive demonstration of the versatility of this gene regulation system (summarized in [@b8]). In this review we describe the properties of *tet* regulation pertinent to the above outlined special tasks, present an overview of various applications of TetR in prokaryotes and finally review the attempts to expand the potential applications by engineering regulator--effector pairs with novel properties.

The origin of *tet* regulation
==============================

Resistance to the antibiotic tc in Gram‐negative bacteria is mostly brought about by proton‐dependent antiport of the drug accomplished by the membrane‐residing TetA protein (reviewed in [@b20]). The conserved genetic organization and sequence variants of this regulatory system have been summarized in [@b45]). Currently, there are 14 sequence variants known which are widespread among the eubacteria, occurring in 35 genera covering five of 24 phyla ([@b9]; [@b1]; [@b101]). The common genetic structure consists of the *tetA* gene encoding the membrane‐spanning tc antiporter which is under transcriptional control of the tc‐responsive Tet repressor TetR encoded by the divergently oriented *tetR* gene. TetR is an all α‐helical protein and is active as a homodimer both in its DNA‐bound and in its induced state ([Fig. 1](#f1){ref-type="fig"}); detailed information on the TetR structures has been reviewed ([@b84]). As tc blocks protein biosynthesis, its inducer potency must clearly surpass its inhibitory capacity, hence induction for these determinants has had to acquire a remarkable sensitivity. Owing to the fact that even low level expression of the membrane protein TetA is disadvantageous for bacterial cells as demonstrated for *E. coli* ([@b71]), repression of this gene is very efficient. This rarely found combination of low basal expression with efficient induction is the result of the thermodynamic properties of the underlying regulatory reactions. The specificity and efficiency of regulation result from a high binding constant of TetR to *tetO*, while at the same time the affinity for non‐operator sequences is rather low compared with other repressors ([@b8]). This favourable affinity ratio for binding of specific over non‐specific DNA sequences implies that TetR can exert efficient regulation in organisms with much larger genomes than *E. coli*. Furthermore, these properties lead to a high occupancy of *tetO* and, thus, contribute to efficient repression. In addition, the distinct genetic organization of these determinants as studied extensively for the tc resistance determinant *tet*(B) found on transposon Tn*10* contributes to the efficiency of regulation. The detailed genetic arrangement is displayed in [Fig. 2](#f2){ref-type="fig"} and indicates that *tetR* and *tetA* are separated by a total of three promoters and two *tet* operators (*tetO*~1~ and *tetO*~2~) in their intergenic region. The functional analysis of the two operators revealed that both of them can be bound independently by TetR, and that occupation of *tetO*~1~ inhibits *tetR* and *tetA* transcription, whereas the occupation of *tetO*~2~ represses only the expression of the exporter protein ([@b68]). Notably, the affinity of *tetO*~2~ for TetR is about twice larger than that for *tetO*~1~. TetR‐mediated regulation of tc export has been reviewed ([@b34]).

![A. Structure of the TetR--*tetO* complex as determined by [@b72]). TetR is depicted in a ribbon representation with one monomer coloured grey and the other coloured blue. The numbers of helices are given in the blue monomer. Note that the linker sequence between helices α8 and α9 of both monomers is not resolved. The bound DNA is depicted as a ball‐and‐stick model. B. Structure of TetR in the tc‐bound form according to [@b46]). Representations are as in (A). Tetracycline is given as orange spheres, with two molecules bound to the two inducer‐binding pockets of TetR.](mbt0001-0002-f1){#f1}

![Sequence of the *tetR*--*tetA* intergenic region of Tn*10* according to [@b18]). The three promoters are depicted as thin arrows with the --35 and the --10 regions symbolized by black boxes. The arrow tips mark the transcription start points. Squares indicate *tetO* sequences, and the black or grey filled arrows indicate the start codons of *tetR* or *tetA* respectively.](mbt0001-0002-f2){#f2}

*tet* regulation of Tn*10* obeys a closed‐loop logic of continuous control ([@b5]) and it has been previously assumed that autoregulation of TetR serves the purpose of preventing induction when the TetR level may be diluted by cell division. While this is still a valid consideration, more recent data from artificially constructed regulatory circuits indicate that negative autoregulation results in a large decrease of the response time after administration of the inducer ([@b83]). In the light of these results, it is very well possible that autoregulation of *tetR* also contributes to the high sensitivity of induction by small amounts of drug and to less heterogeneity in *tetA* expression in the affected cell population ([@b30]). The *tetO*~2~operator exclusively controlling *tetA* expression would then be important for keeping the induced expression of *tetA* at a moderate level so that toxicity of this protein would not counteract protection from tetracyclines. Thus, shaped by the outlined evolutionary pressure, gene regulation mediated by TetR combines the seemingly contradictory features of tight repression and sensitive induction.

The use of Tn*10* and transposon‐derived elements to obtain tc‐regulatable transcriptional fusions
==================================================================================================

Creating gene disruptions in bacteria is often achieved using transposons ([@b38]), which also frequently exert polar effects on adjacent genes. For Tn*10*, it had been realized early on that, while inactivating the gene located at the insertion site, this element also confers tc‐inducible transcription of regions located upstream or downstream of that site ([@b57]). The induced expression levels, however, are usually quite low, thus limiting the use of full‐length Tn*10* to generate mutants with tc‐dependent phenotypes. Deletion variants of Tn*10* have been constructed and resulted in much higher efficiency of tc‐inducible expression. A mini‐Tn*10*, basically consisting only of the *tetR*/*tetA* divergon, and the terminal sequences of the flanking IS*10* elements ([@b106]), was used to obtain tc‐inducible auxotrophs in *E. coli* ([@b97]). An improved version of this Tn*10*deletion mutant, called T‐POP ([@b80]), found use in *E. coli* and *Salmonella* for gene analysis. A T‐POP‐controlled flagella master operon in *Salmonella enterica* serovar Typhi served to analyse the temporal expression of components of the flagella motor from that operon after tc induction. A general search for conditional auxotrophic mutants in *E. coli*, using a random insertion library of T‐POP, has resulted in four strains with the desired phenotype ([@b44]), while an *E. coli* strain deleted for the porin‐encoding *tsx* gene has been randomly mutagenized by T‐POP to identify tc‐controllable suppressors ([@b15]). Taken together, these Tn*10* derivatives with enhanced tc‐dependent outward transcription have proven to be useful in *E. coli* and its close relative *Salmonella*. Both elements do not bear transposase genes, but are mobilized by transposase encoded within the bacteria.

A completely different approach towards insertional mutagenesis was pioneered by Reznikoff and colleagues. Their method involves the *in vitro* assembly of a purified hyperactive mutant transposase derived from transposon Tn*5* and DNA fragments containing optimized transposase recognition sites at both ends. A ternary complex formed by two molecules of transposase and one linear DNA fragment (called a transposome) can efficiently insert into target DNA *in vitro* or be transferred via electroporation into *E. coli* ([@b31]). Upon integration of the DNA, genetically stable insertion mutants are obtained because the transposase is encoded neither on the integrative element nor elsewhere in the target cell and hence cannot remove the integrated DNA from the insertion locus at a later time point. This approach has been utilized to generate mutants with tc‐dependent phenotypes by placing a modified *tetA* promoter on an insertion element termed InsTet^G--^1 ([@b62]). Electroporation of InsTet^G--^1 transposomes into *E. coli* or *S. enterica* serovar Typhimurium that express TetR resulted in tc‐inducible auxotrophic or lethal strains. A similar transposome approach has also been used to obtain *Bacillus subtilis*strains with such phenotypes by random insertion. To this end, different variants of integrative elements, designated InsTet^G+^, were constructed which harbour an outward‐directed tc‐responsive promoter suitable for *B. subtilis*. TetR was encoded either on the elements themselves, on a plasmid or on the chromosome ([@b11]).

Utilization of *tet* expression systems in Gram‐negative bacteria
=================================================================

The first plasmid‐based tc‐controlled expression system used a *tetA--lacZ* translational fusion as reporter ([@b115]). While this group exploited the native *tetA* promoter of Tn*10*, [@b66]) developed a synthetic *tet*‐sensitive promoter, termed P~LtetO‐1~, composed of the phage λ P~L~ promoter with *tetO* sequences replacing λ cI repressor binding sites. The efficiency of this set‐up was compared with two differently regulated expression systems in *E. coli*, and the excellent regulatory properties of *tet* controlled gene expression were quantitatively established. Among the regulatory systems tested, the *tet* set‐up produced the largest regulatory window with about 5000‐fold induction of gene expression using anhydrotetracycline (atc) as an inducer and the lowest basal expression level estimated to amount to only one mRNA molecule per three *E. coli* cells in the repressed state. These results demonstrated clearly that *tet*‐based regulatory systems would have the potential to control the expression of genes encoding poisonous products and proteins which exert their biological function with only a few copies per cell. It should be noted, however, that accomplishing such low expression levels in the reduced state requires careful adjustment of the regulatory system with respect to the ratio of TetR molecules to the copy number of regulated promoter(s) in the cell (see below). This work also highlighted the use of luciferase as a reporter enzyme which is useful for determining the repressed state expression level, because very few copies of the protein already lead to a detectable enzymatic activity.

These results paved the way for several applications specifically requiring low expression levels of a desired target protein. In particular, the property of tight repression achievable by *tet* regulation has been exploited for conditional expression of Flp recombinase or the meganuclease I‐Sce, to obtain *E. coli* strains in which site‐specific recombination, or DNA restriction events, respectively, depended strictly on the addition of an inducer for TetR ([@b76; @b77; @b75]). These studies also clearly demonstrated that *tet* regulation is able to repress the expression of enzymes mediating irreversible genetic modifications to levels completely alleviating their activities. This is further highlighted by a *tet* controlled two‐stage expression system in which a cloned gene needs to be inverted by Flp recombinase so that the reading frame becomes attached to the promoter ([@b91]). Flp recombinase in turn is provided under *tet* control resulting in a well‐regulated all‐or‐none expression system. The tight repression observed in the work described above is also due to the high affinity and specificity of TetR for *tetO*. The latter characteristic is very much supported by the remarkably low affinity of TetR for non‐cognate DNA, thereby reducing loss of regulator molecules by binding to unspecific, non‐*tetO* sites on chromosomal DNA (reviewed in [@b45]). This highly specific DNA binding was exploited for the construction of *E. coli* strains containing multiple *tetO* repeats in various sections of the chromosome and expressing a TetR--eYfp fusion protein retaining binding activity for *tetO*, so that the assembly of this fusion protein on the chromosome became observable by confocal microscopy ([@b74]). These authors demonstrated clearly that binding of this repressor--reporter fusion to DNA leads to a block of replication at several sites of the chromosome, which could be relieved by administering an inducer for TetR.

*tet* controlled expression of *rpoH* was used to determine the σ^32^ regulon and to examine the degradation characteristics of this alternative sigma factor of *E. coli* ([@b112]). To this end an *E. coli* strain with *tetR* ectopically integrated into the chromosome was used. A similar strain has been exploited for expression of inhibitory single‐stranded DNA (ssDNA) to block *ftsZ* expression ([@b98]). It turned out that induction of ssDNA synthesis led not only to the loss of FtsZ activity but also stopped cell growth. Hence, the authors concluded that FtsZ would be a validated target for the development of anti‐infectives. This work was followed up by expressing a randomly constructed ssDNA library under *tet* control to screen for essential genes in *E. coli*. This approach was validated by the fact that inhibition of RNA polymerase activity via induction of a respective ssDNA fragment resulted in growth arrest ([@b99]). A *tet*‐regulation system has been used to control expression of an antigen from *Plasmodium falciparum* in *S. enterica* serovar Typhi for human vaccine production ([@b78]). Remarkably, it has also been demonstrated that a respective *Salmonella* strain can be induced in the liver and spleen of infected mice, where the majority of the bacteria retained the expression plasmid for at least 14 days. Recently, a shuttle vector with a *tet* controlled expression system has been constructed for *E. coli* and the recently identified bacterium *Laribacter hongkongensis* which is associated with gastroenteritis ([@b107]). Using two common reporters, Gfp and glutathione *S*‐transferase, it has been demonstrated clearly that *tet* regulation was efficiently possible in both bacteria using one common set‐up. Finally, *tet* regulation was established in *Vibrio cholerae* to identify genes which are differentially expressed dependent on growth *in vitro* or during infection of mice. This was achieved by random chromosomal integration of promoterless *tetR* which, upon insertion downstream of an active promoter, led to repression of a *tet* controlled *gfp* gene ([@b47]).

*tet* regulation for phage display systems and production of secreted proteins
==============================================================================

*tet* controlled transcriptional regulation was exploited for the expression of secreted F~ab~ fragments of antibodies by constructing a generally applicable multicopy expression vector with tight repression exerted by TetR ([@b93]). The results of this study showed very low background expression levels in the uninduced state and efficient induction of F~ab~ fragment expression in the presence of atc and subsequent secretion of the product into the periplasm of several *E. coli* hosts. This approach has been applied to the expression of several antibody fragments, which gave rise to high yields of the desired proteins ([@b85]; [@b33]). Accordingly, the expression of so‐called 'anticalin' mutant pools of lipocalin‐like folded proteins with variable ligand‐binding specificities can efficiently be controlled by a similar *tet* system ([@b13]).

Indeed, *tet* control showed a distinct general advantage for the construction of mutant libraries for screening purposes, e.g. in phage display ([@b21]; [@b110]), where the choice of expression system is crucial for the maintenance of the diversity in mutant libraries in *E. coli* because the property of the expressed protein often has a pronounced effect on the growth rate of the respective cell. The fastest growth rate is usually exhibited by cells that do not produce any protein from the library. Hence, they would outgrow candidate cells unless repression is tight enough to avoid all library imposed growth effects. This is an important point because any screening protocol will only enrich positive candidates, may it be done by SELEX, cell sorting or any other method. The following expansion of the candidate pool suffers from potential growth effects resulting in the worst case in elimination of slow‐growing candidates. Hence, the complexity in tightly controlled mutant banks remains much larger as compared with less tightly controlled ones. Tightly regulated *tet* expression systems were promoted for the isolation of mutants with desired properties from degenerated peptide libraries by phage display ([@b73]; [@b103]). A general comparison of *tet* regulation with other systems for heterologous protein expression can be found in a recent review ([@b100]).

*tet* regulation in Gram‐positive bacteria
==========================================

While export‐mediated tc resistance is always tightly regulated by TetR in Gram‐negative bacteria, the frequently occurring *tet*(K) determinant in *Staphylococcus aureus* lacks a TetR variant (reviewed in [@b20]). TetR‐mediated transgene regulation has been established in Gram‐positive bacteria by meeting the different promoter requirements of these organisms to ensure both proper expression of the regulator and adequate regulation of a target gene. Although the conserved --10 and --35 regions of σ^A^ promoters match with the ones of their σ^70^ counterparts of *E. coli* ([@b41]), the *B. subtilis* RNA polymerase shows stricter discrimination. Furthermore, *B. subtilis* promoters often need so‐called --16 regions to function efficiently ([@b104]; [@b16]). Accordingly, an unmodified Tn*10*‐based regulatory system was not functional in *B. subtilis*. To circumvent this obstacle, the *B. subtilis xylA* promoter was equipped with one or two *tet*operator sequences in a construct termed P~xyl/tet~, which could be regulated in *B. subtilis* by *tetR* placed in divergent orientation, driven by a modified autoregulated promoter termed P\* ([@b29]). This novel plasmid‐based expression system marked the beginning of *tet* regulation in Gram‐positive bacteria. The need for efficient and reliable target validation methods in pathogenic Gram‐positive bacteria provided the motivation for applying this system in *S. aureus* and different streptococci. A comparison between P~xyl/tet~and two other inducible systems in *S. aureus* ([@b111]) was followed by a thorough characterization of *tet* regulation using P~xyl/tet~ controlled *gfp* expression. These studies established that tc control is effective not only when used in bacteria cultured *in vitro*, but can also be applied to eukaryotic cell cultures for intracellular bacteria, and even worked well with bacteria in animal models for infectious diseases ([@b6]). P~xyl/tet~ has also been used to overexpress a small untranslated RNA, SR1, to gain insights into its function ([@b64]).

An improved *tet*‐regulation system was recently established, which produced much higher regulation factors in *B. subtilis*. This was achieved via enhanced, constitutive expression of TetR ([@b52]). It is expected that this strategy would also improve *tet*regulation in other Gram‐positive bacteria of low G+C content.

A different mode of *tet* regulation has often been used in *S. aureus*, in which a target gene is conditionally downregulated by dosed expression of antisense RNA employing tc‐sensitive promoters. The result of this approach is the tc‐induced silencing of a gene, as opposed to induction of expression. The same goal can nowadays also be accomplished using TetR variants, called revTetR, which require tc to bind to *tetO* (see below for details). The antisense method is particularly well suited for regulation of essential genes which are left untouched in their original genetic locus, but can thus nevertheless be regulated *in trans*. The efficiency of *tet* controlled antisense RNA regulation has been demonstrated for the *hla* gene, assumed to play an important role in pathogenicity ([@b48]). The tc‐induced knockdown of *hla* expression completely eliminated lethality of an *S. aureus* infection in mice, thereby also establishing that *tet* regulation can be effectively used to control the expression of genes from staphylococci in mammalian infection models. This study was soon followed by the comprehensive analysis of essential genes in *S. aureus* using a *tet* controlled random pool of antisense RNA, where essential genes for infection have also been characterized in infected mice ([@b50]).

*tet*‐regulated antisense approaches have been applied for further studies of *S. aureus* genetics: the importance of a two‐component regulatory system has been established, which turned out to be essential and, when expressed at lower levels, increased the organism\'s susceptibility for phosphomycin ([@b96]). An essential glycoprotease has been identified ([@b113]), which has recently been characterized ([@b114]), and *tet* controlled antisense‐mediated knockdown of a polypeptide deformylase resulted in an increased sensitivity for an antibacterial compound targeting this enzyme ([@b108]). It is noteworthy that in *B. subtilis* direct and antisense control exerted by P~xyl/tet~ leads to similar repressed expression levels as demonstrated by Western blots directed against HPr kinase/phosphorylase (HPrK/P), a central player in carbon catabolite regulation in *B. subtilis*, that was regulated using both approaches ([@b12]). Even the lowest accomplishable expression level did not yield the phenotype of an HPrK/P knockout mutant. This result indicates that some genes, presumably especially the ones encoding regulatory functions, can exert their phenotypes at very low expression levels. The *tet* controlled antisense RNA strategy for target identification, validation and mechanism of action has been thoroughly reviewed ([@b109]).

P~xyl/tet~regulation has also been utilized for the construction of genetic tools for strain construction in *S. aureus*. Two methods were introduced, one allowing for allelic replacement, thereby yielding regulated expression of essential genes ([@b27]), and another enabling selection against the episomal state of integrative plasmids ([@b2]). Targets from the bacterial fatty acid biosynthesis enzymes have been expressed in a *tet* controlled manner in *S. aureus*, and these strains have been used to adjust so‐called sensitized phenotypes for the evaluation of drug candidates. A sensitized phenotype results from adjusting the expression level of the target protein below the wild‐type level which increases the effect of a potential drug directed against this target, thereby increasing the number of lead compounds derived from such a screen. This approach has been extensively used to characterize a variety of inhibitors of bacterial fatty acid synthesis ([@b65]) and to confirm the mode of action of novel compounds in whole‐cell assays ([@b49]). In addition to *S. aureus*, streptococcal species have been the preferred bacteria for application of the *tet* system. The effect of an eukaryotic‐type Ser/Thr kinase has been evaluated in pathogenic group B streptococci ([@b79]) by using *tet* controlled expression of that kinase for complementation of knockouts. *tet* regulation has been found to be superior to other regulatory systems for setting up a conditional knockout strategy for identifying essential genes in *Streptococcus mutans*([@b105]). While these two studies made use of the fact that P~xyl/tet~is also active in streptococci, two different tc‐regulatable promoters have been developed for *Streptococcus pneumoniae*([@b95]). These constructs were subsequently used to adjust the expression levels of target genes in that species by *tet* regulation ([@b102]).

The last years have also seen the successful adaptation of tc‐dependent expression systems for the analysis of genes in mycobacteria including the pathogenic strain *Mycobacterium tuberculosis*. The application in this organism included antisense control in free‐living and intracellular bacteria ([@b14]), the construction of conditional lethal knockouts of *ftsZ* by a tc‐dependent promoter leading to a more than 100‐fold induction ([@b25]), and the construction of a tc‐addressable conditional auxotroph containing *trpD* under *tet* control in single copy, which resulted in tight control of expression ([@b17]). Furthermore, *tet*‐regulated expression constructs for use in *Streptomycetes* have been described and yielded about 270‐fold induction in members of that genus ([@b82]).

Use of TetR for bacterial biosensors monitoring tc
==================================================

The high affinity of tc and its derivatives for TetR combined with the sensitive induction of reporter gene expression has been used to construct bacterial biosensor strains to detect tc in various environments. Whole‐cell biosensors based on *tet*‐dependent expression of Gfp in *E. coli* have been used for detection and quantification of tetracyclines in the rat intestine ([@b3]). When the *tet*(M) resistance determinant against tetracyclines was also introduced into that reporter strain, it resulted in a remarkable expansion of the concentration range of tetracyclines that could be detected ([@b4]). In a similar approach, an *E. coli* strain expressing Gfp in a *tet*‐dependent manner was used to track oxytetracycline synthesis by *Streptomyces rimosus* in sterile soil samples ([@b36]). This whole‐cell biosensor may also be equipped with different reporter genes encoding β‐galactosidase (β‐gal) or luciferase. Such constructs can be transferred to other Gram‐negative bacteria by conjugation, and respective *E. coli* strains were useful for determining oxytetracycline in milk or pork serum ([@b61]).

Use of TetR for synthetic biology
=================================

The rapidly developing area of synthetic biology attempts to develop quantitative models for complex regulatory circuits in living cells on the basis of quantitative interpretations of simple building blocks from which such complex regulation may be constructed in the future. Currently, artificial genetic circuits are constructed mostly in *E. coli* or yeast, using well‐established transcription control systems in various combinations. The most often used bacterial promoters in such circuits are the lambda p~l~/p~r~ promoters which are supplied with either their natural lambda operators, or *lac* operator or *tet*operator, so that they respond to various inducers. TetR is frequently used in these constructs for the reproducible adjustment of different expression levels of other repressors or activators. It was found that TetR with a C‐terminal tag enforcing degradation can be well suited for synthetic biology approaches involving time‐resolved experiments ([@b26]; [@b35]), while in a different study a TetR single‐amino‐acid exchange mutant for decreased operator binding, which was furthermore tagged by eGfp at the C‐terminus, was used ([@b7]). In fact, several further Gfp proteins were fused to TetR, while both portions of the fusion construct retained their activity ([@b69]; [@b83]; [@b63]). Detailed information about engineered gene regulatory networks in general and synthetic biological circuits involving TetR can be found in some excellent reviews ([@b51]; [@b67]; [@b94]).

Overview of bacterial *tet* regulation architectures and parameters of induction
================================================================================

*tet*regulation in bacteria requires expression of a TetR variant and a promoter equipped with *tetO*. The native arrangement in Tn*10*, in which the *tetR* and *tetA* promoters P~R1~, P~R2~ and P~A~ overlap, share *tetO* sequences ([Fig. 2](#f2){ref-type="fig"}) and, hence, mutually influence each other ([@b45]), has been exploited in several studies ([@b115]; [@b106]; [@b19]; [@b97]; [@b76; @b77; @b75]; [@b80]; [@b91]; [@b90]; [@b37]; [@b56]; [@b36]; [@b3; @b4]; [@b44]; [@b15]). One study has made use of the *tet*(Z) determinant found in *Corynebacterium glutamicum* ([@b14]).

The P\*/P~xyl/tet~system is an adaptation of this intertwined bidirectional promoter/operator arrangement to accommodate the stricter sequence requirements for promoters in Gram‐positive bacteria ([@b29]). This set‐up involves autoregulation of *tetR* expression and has also been applied in Gram‐positive species of low G+C content from the genera *Bacillus*, *Staphylococcus* and *Streptococcus* ([@b48; @b50; @b49]; [@b111]; [@b6]; [@b27]; [@b11; @b12]; [@b17]; [@b64]; [@b79]; [@b96]; [@b105]; [@b113]; [@b2]; [@b108]), as well as for the Gram‐negative bacterium *Laribacter hongkongensis* ([@b107]). Using the strong P~xylA~ of *B. subtilis* or synthetic promoters to drive *tetR*expression increased the regulatory window obtained with P~xyl/tet~([@b11]; [@b52]). Several examples indicate that *tetR* autoregulation does not generally offer an advantage for regulation efficiency in transgenic set‐ups; for example, the *tet*(Z) determinant used in mycobacteria displayed considerable leakiness in the repressed state ([@b14]) and, accordingly, P\*/P~xyl/tet~ controlled complementation of a serine/threonine kinase occurred even in the absence of inducer ([@b79]). Compounds like atc combine a reduced antibiotic activity with increased induction and hence can be administered in higher concentrations to obtain full induction even with high TetR amounts. In fact, uncoupling *tetR* expression from the regulated promoter has yielded some of the largest regulatory windows with *tetR* expressed from a transcriptional fusion with β‐lactamase ([@b93]) or by phage promoters ([@b66]; [@b78]; [@b98]; [@b99]; [@b82]).

Numerous *tet* controlled promoters have been described, which differ in the number and positioning of *tetO* sequences. *Bacillus subtilis* promoters with two *tetO* sites can be repressed stronger than those with one operator ([@b52]), albeit at the cost of incomplete induction in case of P\*/P~xyl/tet~ ([@b29]; [@b11]). The only promoter with three *tetO* sites has been used in *streptomycetes* ([@b82]). In the often used P~LtetO‐1~ promoter, the two *tet* operators flank the --35 site ([@b66]), while they bracket the --10 region in P~tetA~ and P~xyl/tet~. [Figure 3](#f3){ref-type="fig"} summarizes the arrangements of *tetR* and the respective target gene with respect to vicinity and episomal or chromosomal location and shows which ones were used in various studies. In addition, [Fig. 4](#f4){ref-type="fig"} schematically depicts some most efficient and/or most often applied promoters for target gene expression with corresponding induction factors that have been determined.

![Different architectures of *tet*‐regulation system are shown. Depicted are *tetR* (black arrow) and the target gene (grey arrow), controlled by a tc‐sensitive promoter (grey bent arrow with grey box symbolizing *tetO*). Situations are: (A) target gene and *tetR* on one plasmid; (B) target gene and *tetR* on two distinct plasmids; (C) target gene and *tetR* on chromosome; (D) target gene on plasmid, *tetR* on chromosome; (E) target gene and *tetR* on chromosome, adjacent; (F) target gene and *tetR* on chromosome, distinct loci. Remarks: Several studies applied more than one architecture. The articles by [@b76; @b77; @b75]) describe the use of plasmids which were subsequently integrated into the genome. [@b74]) applied a plasmid expressing TetR for non‐transcriptional regulation. [@b2]) used *tet* regulation to counterselect for the episomal state of the DNA. In contrast to the drawing in the head of the figure, [@b82]) placed *tetR* collinear to, and hence uncoupled from, the target gene, which is also true for the construct of [@b93]) and derivatives thereof. The *tet*‐regulation vector developed by [@b107]) has only approximately one copy per *Laribacter* cell.](mbt0001-0002-f3){#f3}

![Representation of selected promoters for *tet*regulation. The architecture is schematically depicted and not drawn to scale. --35 and --10 denote the respective base‐pair hexamers of the promoters. 'O' designates *tet* operator. The indicated approximated induction factors (IF) were achieved under circumstances briefly outlined at the right side. n.d., not determined.](mbt0001-0002-f4){#f4}

For relief of repression, the predominant inducer of *tet*‐regulated genes in literature is tc, followed by atc, while also further tc derivatives were assayed for TetR induction in various bacteria ([@b19]; [@b59]; [@b61]; [@b14]). Doxycycline (dox), the preferred compound for mammalian *tet* systems, is rarely the compound of choice ([@b105]), probably due to antibiotic activity. One means to overcome growth inhibition imposed by tc is the expression of suitable resistance factors which allow for administration of otherwise harmful concentrations of the drug ([@b97]; [@b56]; [@b4]; [@b108]). In turn, it then takes much higher tc concentrations for maximal expression of a *tet*‐controlled gene ([@b19]). Some early applications of *tet* regulation in *E. coli*used a heat‐inactivated chlortetracycline stock solution for induction ([@b76; @b77; @b75]; [@b91]; [@b90]). This treatment probably leads to rapid degradation of the drug, and we suspect that trace amounts are converted to atc, which has a decreased antibiotic activity and is a much more potent inducer of TetR ([@b22]). These properties have made atc the preferred inducer for *tet* controlled bacterial expression systems nowadays. It must be kept in mind, however, that atc decomposes upon irradiation with light leading to rapid changes in inducer concentration at longer exposure times.

A commonly applied concentration of tc as inducers is 200 ng ml^--1^ (equalling \~0.5 µM); however, *tet* regulation offers doseable expression dependent on inducer concentration, as demonstrated by [@b19]), [@b33]) and [@b98]) in *E. coli*. Similar analyses confirming doseability of *tet* regulation were conducted with staphylococci ([@b111]; [@b6]; [@b27]; [@b96]; [@b113]) and mycobacteria ([@b14]; [@b17]; [@b25]). The advantageous pharmacokinetic properties of tc also enable the induction of intracellular bacteria within eukaryotic cell cultures ([@b6]; [@b14]; [@b25]), or even in infected mice and rats ([@b48; @b50]; [@b6]; [@b78]; [@b3]) (see above), where the drug is injected or given orally via drinking water. Although the inducer concentration which actually reaches the bacterial cells within the hosts cannot easily be determined, relative dose--response correlations have been established ([@b6]; [@b50]; [@b3]).

Concerning induction time and the duration of the drug\'s exposure, [@b93]) found an increase in F~ab~ fragment production expressed via a *tet* system 1 h after induction. A similar response time was determined with *S. enterica* serovar Typhimurium cells harbouring a *tet*‐controlled flagellar master operon, which gained motility approximately 45 min after addition of tc ([@b56]), which, according to the timescale, is consistent with early findings by [@b115]). Various studies have confirmed a graded time response dependence of *tet*‐inducible transcription ([@b48]; [@b111]; [@b6]; [@b98]; [@b25]; [@b96]; [@b99]; [@b105]; [@b107]; [@b112]; [@b113]). Interestingly, [@b74]) could demonstrate impressively that as early as 5 min after addition of atc, cells with TetR bound to *tetO* arrays on the chromosome were relieved from stalling in a non‐replicative state.

Contrasting to the induction time, a reversal of an induced phenotype was obtained 4 h after the inducer was washed out of the cells ([@b44]). To quickly achieve both on‐ and off‐states, it would hence be desirable to have a toggle‐switch architecture at hand. Such a set‐up has been described, exploiting TetR and LacI that mutually control each other and a target gene ([@b28]). It is also conceivable to express both wt‐TetR and one of some recently constructed revTetR variants, which display a stringently different inducer preference (see below), to rapidly switch between the on‐ and the off‐state of a target gene by administering different tc derivatives.

Modifications of *tet* regulation: revTetR and TetR mutants employing different effectors and operators
=======================================================================================================

Most applications of *tet* regulation in bacteria have used the wt‐TetR variant from Tn*10*, called TetR(B). However, genetic and thermodynamic analyses have revealed that a chimera, designated TetR(BD) containing the DNA reading head of TetR(B) and the protein core of TetR(D) (encoded by the *Salmonella* plasmid RA1), exhibits enhanced stability and better regulatory properties ([@b87]). The stability of TetR is further enhanced in a monomeric single‐chain TetR protein called scTetR, which has been constructed by fusing the C‐terminus of the first monomer to the N‐terminus of the second monomer by means of a flexible polypeptide linker. This variant retains all activities in *E. coli* ([@b54]), and fused to a eukaryotic read‐out domain also in eukaryotes ([@b60]). Genetic stability of the *sctetR* gene is assured by employing alternative codons in one‐half of the gene thereby reducing the similarity between the two *tetR* sequences.

Much effort has been put into the understanding and engineering of TetR interactions with DNA or effectors. *tetO* sequences changed in one base pair of each palindromic half‐side ([Fig. 5A](#f5){ref-type="fig"}) were used to develop two TetR(B) variants with altered operator preferences ([@b40]; [@b39]). Recently, another TetR mutant has been developed, which specifically recognizes an operator with two altered positions in each palindromic half‐site (M. Krueger, O. Scholz, S. Wisshak, and W. Hillen, unpubl. results). As a result, TetR variants can bind to promoters with mutant *tet* operators to repress different downstream genes in the same cell. To accomplish independent regulation of these genes, the respective TetR variants must furthermore be specific for distinct inducers. TetR is not induced by tc derivatives lacking the 4‐dimethylamino grouping like 4‐de‐dimethylamino‐atc ([Fig. 5B](#f5){ref-type="fig"}); however, *in vitro* evolution has yielded a triple mutant of TetR, which is induced exclusively by this compound and not by atc, tc or dox ([@b43]).

![A. Depiction of *tetO~2~* and two derived operator variants with single‐base‐pair exchanges in each half‐side. B. Chemical structure of tc (with key carbon atoms numbered), atc and 4‐de‐dimethylamino‐atc. C. Regulation principle of wt‐TetR (top) and revTetR (bottom). wt‐TetR is depicted with black ovals representing the protein core and grey ovals symbolizing DNA reading heads. revTetR is depicted accordingly with hatched fillings. A *tet* controlled target gene is repressed (grey arrow) or induced (white arrow), dependent on the absence or presence of effector molecules (white triangles) bound to TetR.](mbt0001-0002-f5){#f5}

Independent *tet* regulation of two genes in one prokaryotic cell has been accomplished by employing TetR variants with such different characteristics. To this end, two TetR variants differing (i) in their dimerization domain sequence to prevent heterodimerization \[classes (BD) versus (B) ([@b87])\], (ii) in their DNA binding site specificity (*tetO* versus *tetO*‐4C) and (iii) in their inducer specificity (4‐de‐dimethylamino‐atc versus atc) were expressed in the same *E. coli* cell, yielding selective regulation of two reporter genes ([@b55]). Furthermore, a novel gain of function scTetR variant with two different inducer‐binding pockets requires both of these compounds for induction, indicating that TetR detaches from *tetO* only when two inducer molecules are bound ([@b54]).

More than 100 revTetR variants display enhanced *tetO* binding in the presence of tetracyclines ([Fig. 5C](#f5){ref-type="fig"}). Some of these novel regulators have regulatory properties of similar efficiencies as wt‐TetR ([@b53]; [@b88]); however, their exploitation in prokaryotes is only beginning. revTetR variants have been used to regulate the InsTet^G--^1 element in *E. coli* ([@b62]), InsTet^G+^ variants in *B. subtilis*([@b11]), and in another *B. subtilis* architecture revTetR displayed at least the same regulatory efficiency as wt‐TetR ([@b52]). It was recently demonstrated that the different phenotypic alterations of shifted operator and inducer preference and reverse behaviour of TetR variants can functionally be combined in novel regulators, which, e.g. only in the presence of 4‐de‐dimethylamino‐atc bind to *tetO* ([@b10]; [@b42]). A dodecapeptide, termed Tip (transcription‐inducing peptide), isolated by phage display has pronounced inducing capacities for TetR(B) ([@b58]). This is the first known inducer for TetR belonging to a different class of substances. A properly constructed insertion element created random translational fusions with Tip in *E. coli*. The expression levels of the Tip fusion proteins could be quantified by *tet*‐regulated reporter gene expression ([@b86]).

Conclusions
===========

*tet* regulation has proven very useful for inducible transgene expression in both eukaryotes and prokaryotes. Its usefulness concerning the latter group of organisms is reflected not only by spanning a considerable repertoire of species, ranging from *E. coli* to high G+C Gram‐positive bacteria, but also by the published and ongoing development of *tet*‐regulation systems for diverse applications. It seems likely that we will witness both the elaboration of new and even more efficient set‐ups as well as the adaptation of established systems to further bacteria, such as *Chlamydiae* ([@b24]). Exploiting Tet repressors with different modes of allostery or ligand‐binding specificities (or both) will pave the way for multigene regulation set‐ups, and, indeed, first steps have already been taken in this direction ([@b55]). Further developments are under way and one can imagine that novel *tet* systems will be tailored for any given task in any prokaryotic organism of choice.
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Note added in proof
===================

While finishing this article, we became aware of further recent studies employing *tetR* in bacteria. Wright *et al.* (*Cell Microbiol*, 2007, doi:10.1111/j.1462‐5822.2007.00952.x) used the *tet*‐regulatory region of a commercially available *E. coli* strain to construct a conditional *fim* mutant and to analyse the effects of pili on biofilm formation of a uropathogenic *E. coli* variant. Also Da Re *et al.* (*Appl Environ Microbiol*, 2007, **73**, 3391--3403) studied the effects of regulated genes promoting biofilm formation in *E. coli* applying integrative sequences, comparable to InsTet elements described above. According to personal communication with Y. Zhang, *tet*‐regulation has been introduced into the Gram‐negative bacterium *Photorhabdus luminescens* for induction of Red/ET recombineering. Gründling and Schneewind integrated an autoregulated *tetR* gene and a divergently oriented P~xyl/tet~ promoter into the *S. aureus* chromosome to express genes involved in lipoteichoic acid synthesis (*J Bacteriol*, 2007, **189**, 2521--2530 and *Proc Natl Acad Sci USA*, 2007, **104**, 8478--8483). Tahlan *et al.* (*Mol Microbiol*, 2007, **64**, 951--961) made use of synthetic promoters carrying *tetO* to drive expression of *lux* genes in an *E. coli* tc‐biosensor strain. Guo *et al.* (*J Bacteriol*, 2007, **189**, 4614--4623) established gene regulation in *Mycobacterium smegmatis* via revTetR, as proven by conditional expression of *secA1*, essential for *in vitro* growth.
